Both in Pharmaceuticals
Relmada Therapeutics vs Aquestive Therapeutics
Over the past year RLMD returned +50.5% and AQST returned −37.5%; their daily moves had a correlation of 0.17.
RLMD +50.5% AQST −37.5%Growth of $1, one year, split-adjusted
| Metric | RLMD | AQST |
|---|---|---|
| Price | $4.17 | $3.80 |
| Market cap | $444.8M | $476.9M |
| Today | −2.34% | −2.06% |
| 1 month | +27.1% | −17.6% |
| 6 months | −46.9% | −10.2% |
| Year to date | −13.7% | −41.2% |
| 1 year | +89.5% | −41.4% |
| Revenue growth (YoY) | — | +38.1% |
| Gross margin | — | 70.9% |
| Net margin | — | −165.5% |
| P/E (TTM) | — | — |
| Price / sales | — | 8.8× |
| Net cash | $217.7M | $47.8M |
| Dividend yield | — | — |
| Volatility (60d) | 60.0% | 54.2% |
| Short % of float | 14.0% | 25.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).